Noraina Muhamad Zakuan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Noraina Muhamad Zakuan has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Nurul Akmaryanti Abdullah
Universiti Putra Malaysia, Seri Kembangan, Malaysia
4 shared publications - Nur Fariesha Md Hashim
Universiti Putra Malaysia, Seri Kembangan, Malaysia
3 shared publications Nur Fariesha Md Hashim
Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Upm Serdang 43400, Selangor, Malaysia
2 shared publicationsAmirah Alhusna Mohd Yusoff
Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Upm Serdang 43400, Selangor, Malaysia
1 shared publication- Anis Hazirah Azman
Universiti Putra Malaysia, Seri Kembangan, Malaysia
1 shared publication - Anmar Alrawas
Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43300, Malaysia
1 shared publication
Latest Publications
- 13 May 2026
- Published by Springer Nature in Cytotechnology
- Vol. 78 (3) , 116
PX-12 exhibits cytotoxic and anti-migration effects in colorectal cancer cells under Hypoxia-like conditions induced by Dimethyloxalylglycine
Colorectal cancer (CRC) progression is often driven by hypoxia-induced signaling that promotes metastasis through epithelial–mesenchymal transition and invadopodia formation. PX-12, an irreversible thioredoxin-1 (Trx-1) inhibitor, has shown anticancer potential, but its anti-invasive effects under hypoxic conditions remain unclear. This study investigated the cytotoxic, anti-migratory, anti-invasive, and anti-invadopodia activities of PX-12 in hypoxia-induced CRC cells. Human HCT116 cells were exposed to dimethyloxalylglycine (DMOG) to induce hypoxia. Cytotoxicity was assessed using MTT assays, while migration and invasion were evaluated through wound-healing and Transwell assays. Invadopodia formation was quantified using Oregon Green-labeled gelatin degradation assays. Protein expression of HIF-1α and Trx-1 was analyzed via Jess Simple Western system. PX-12 significantly reduced HCT116 cell viability in a dose-dependent manner, with lower cytotoxicity under DMOG-induced hypoxia. PX-12 markedly suppressed cell migration and invasion, particularly under hypoxia-like conditions. Gelatin degradation analysis revealed a significant reduction in invadopodia formation with PX-12 treatment, paralleling effects of the MMP inhibitor GM6001. Although DMOG markedly upregulated HIF-1α expression, PX-12 did not alter Trx-1 protein levels, suggesting that its inhibitory effects may occurs via enzymatic blockade rather than changes in protein expression. PX-12 exerts potent anti-invasive effects by inhibiting migration, invasion, and invadopodia formation in hypoxia-mimicking CRC cells. These findings highlight PX-12 as therapeutic agent targeting hypoxia-driven migratory and invasive behaviors in CRC.
- 13 May 2026
- Published by Springer Nature in Cytotechnology
- Vol. 78 (3) , 116
PX-12 exhibits cytotoxic and anti-migration effects in colorectal cancer cells under Hypoxia-like conditions induced by Dimethyloxalylglycine
Colorectal cancer (CRC) progression is often driven by hypoxia-induced signaling that promotes metastasis through epithelial–mesenchymal transition and invadopodia formation. PX-12, an irreversible thioredoxin-1 (Trx-1) inhibitor, has shown anticancer potential, but its anti-invasive effects under hypoxic conditions remain unclear. This study investigated the cytotoxic, anti-migratory, anti-invasive, and anti-invadopodia activities of PX-12 in hypoxia-induced CRC cells. Human HCT116 cells were exposed to dimethyloxalylglycine (DMOG) to induce hypoxia. Cytotoxicity was assessed using MTT assays, while migration and invasion were evaluated through wound-healing and Transwell assays. Invadopodia formation was quantified using Oregon Green-labeled gelatin degradation assays. Protein expression of HIF-1α and Trx-1 was analyzed via Jess Simple Western system. PX-12 significantly reduced HCT116 cell viability in a dose-dependent manner, with lower cytotoxicity under DMOG-induced hypoxia. PX-12 markedly suppressed cell migration and invasion, particularly under hypoxia-like conditions. Gelatin degradation analysis revealed a significant reduction in invadopodia formation with PX-12 treatment, paralleling effects of the MMP inhibitor GM6001. Although DMOG markedly upregulated HIF-1α expression, PX-12 did not alter Trx-1 protein levels, suggesting that its inhibitory effects may occurs via enzymatic blockade rather than changes in protein expression. PX-12 exerts potent anti-invasive effects by inhibiting migration, invasion, and invadopodia formation in hypoxia-mimicking CRC cells. These findings highlight PX-12 as therapeutic agent targeting hypoxia-driven migratory and invasive behaviors in CRC.
- 30 June 2024
- Published by Penerbit Universiti Kebangsaan Malaysia (UKM Press) in Sains Malaysiana
- Vol. 53 (6) , 1333-1341
Dimethyloxalylglycine (DMOG) Induced Hypoxia Promoted Migratory and Invasive Properties of HCT116 Colon Cancer Cell Line
Hypoxia, a condition characterised by low oxygen levels, leads to increased production of a protein called hypoxia-inducible factor-1 alpha (HIF-1α) in cancer cells. This protein is involved in driving processes such as vascularization, cytoskeletal reorganisation, and epithelial-to-mesenchymal transformation (EMT), which contribute to metastasis. Previous studies used hypoxic workstations, chambers, and incubators to evaluate the effects of hypoxia on colon cancer cell lines. In a cell culture model, hypoxic conditions can also be induced using dimethyloxalylglycine (DMOG) as the hypoxia-mimicking agent. This study aims to investigate the effects of DMOG-induced hypoxia on colon cancer metastasis, focusing on cell migration and invasion. HCT116 cells were subjected to hypoxic conditions by treating them with DMOG, and the expression of HIF-1α proteins was measured at various time points, followed by wound healing and invasion assays. It was found that HIF-1α protein expression increases after 6 h of DMOG induction and persists for 24 h. At 6 and 24 h, a significantly higher percentage of hypoxic cells migrated compared to normoxic cells. The invasion assay demonstrated that hypoxic cells were more invasive than normoxic cells within 24 h. Thus, the increase in migration and invasion of cells is comparable to the increase in HIF-1α expression at 6 and 24 h. These findings suggest that DMOG induces HIF-1α expression in colon cancer cells, leading to enhanced cell migration and invasiveness. The established model can be further utilised in gene knockdown or drug treatment studies to evaluate the effects of hypoxia on cancer cells.
- 30 June 2024
- Published by Penerbit Universiti Kebangsaan Malaysia (UKM Press) in Sains Malaysiana
- Vol. 53 (6) , 1333-1341
Dimethyloxalylglycine (DMOG) Induced Hypoxia Promoted Migratory and Invasive Properties of HCT116 Colon Cancer Cell Line
Hypoxia, a condition characterised by low oxygen levels, leads to increased production of a protein called hypoxia-inducible factor-1 alpha (HIF-1α) in cancer cells. This protein is involved in driving processes such as vascularization, cytoskeletal reorganisation, and epithelial-to-mesenchymal transformation (EMT), which contribute to metastasis. Previous studies used hypoxic workstations, chambers, and incubators to evaluate the effects of hypoxia on colon cancer cell lines. In a cell culture model, hypoxic conditions can also be induced using dimethyloxalylglycine (DMOG) as the hypoxia-mimicking agent. This study aims to investigate the effects of DMOG-induced hypoxia on colon cancer metastasis, focusing on cell migration and invasion. HCT116 cells were subjected to hypoxic conditions by treating them with DMOG, and the expression of HIF-1α proteins was measured at various time points, followed by wound healing and invasion assays. It was found that HIF-1α protein expression increases after 6 h of DMOG induction and persists for 24 h. At 6 and 24 h, a significantly higher percentage of hypoxic cells migrated compared to normoxic cells. The invasion assay demonstrated that hypoxic cells were more invasive than normoxic cells within 24 h. Thus, the increase in migration and invasion of cells is comparable to the increase in HIF-1α expression at 6 and 24 h. These findings suggest that DMOG induces HIF-1α expression in colon cancer cells, leading to enhanced cell migration and invasiveness. The established model can be further utilised in gene knockdown or drug treatment studies to evaluate the effects of hypoxia on cancer cells.
- 9 May 2024
- Published by Elsevier in Life Sciences
- Vol. 348, 122711
Thioredoxin system in colorectal cancer: Its role in carcinogenesis, disease progression, and response to treatment
- 9 May 2024
- Published by Elsevier in Life Sciences
- Vol. 348, 122711
Thioredoxin system in colorectal cancer: Its role in carcinogenesis, disease progression, and response to treatment
- Open Access
An Insight into the Anti-Angiogenic and Anti-Metastatic Effects of Oridonin: Current Knowledge and Future Potential
Cancer is one of the leading causes of death worldwide, with a mortality rate of more than 9 million deaths reported in 2018. Conventional anti-cancer therapy can greatly improve survival however treatment resistance is still a major problem especially in metastatic disease. Targeted anti-cancer therapy is increasingly used with conventional therapy to improve patients’ outcomes in advanced and metastatic tumors. However, due to the complexity of cancer biology and metastasis, it is urgent to develop new agents and evaluate the anti-cancer efficacy of available treatments. Many phytochemicals from medicinal plants have been reported to possess anti-cancer properties. One such compound is known as oridonin, a bioactive component of Rabdosia rubescens. Several studies have demonstrated that oridonin inhibits angiogenesis in various types of cancer, including breast, pancreatic, lung, colon and skin cancer. Oridonin’s anti-cancer effects are mediated through the modulation of several signaling pathways which include upregulation of oncogenes and pro-angiogenic growth factors. Furthermore, oridonin also inhibits cell migration, invasion and metastasis via suppressing epithelial-to-mesenchymal transition and blocking downstream signaling targets in the cancer metastasis process. This review summarizes the recent applications of oridonin as an anti-angiogenic and anti-metastatic drug both in vitro and in vivo, and its potential mechanisms of action.
Open AccessAn Insight into the Anti-Angiogenic and Anti-Metastatic Effects of Oridonin: Current Knowledge and Future Potential
Cancer is one of the leading causes of death worldwide, with a mortality rate of more than 9 million deaths reported in 2018. Conventional anti-cancer therapy can greatly improve survival however treatment resistance is still a major problem especially in metastatic disease. Targeted anti-cancer therapy is increasingly used with conventional therapy to improve patients’ outcomes in advanced and metastatic tumors. However, due to the complexity of cancer biology and metastasis, it is urgent to develop new agents and evaluate the anti-cancer efficacy of available treatments. Many phytochemicals from medicinal plants have been reported to possess anti-cancer properties. One such compound is known as oridonin, a bioactive component of Rabdosia rubescens. Several studies have demonstrated that oridonin inhibits angiogenesis in various types of cancer, including breast, pancreatic, lung, colon and skin cancer. Oridonin’s anti-cancer effects are mediated through the modulation of several signaling pathways which include upregulation of oncogenes and pro-angiogenic growth factors. Furthermore, oridonin also inhibits cell migration, invasion and metastasis via suppressing epithelial-to-mesenchymal transition and blocking downstream signaling targets in the cancer metastasis process. This review summarizes the recent applications of oridonin as an anti-angiogenic and anti-metastatic drug both in vitro and in vivo, and its potential mechanisms of action.
- Open Access
Identification of Potential Chemical Substrates as Fuel for Hypoxic Tumors That May Be Linked to Invadopodium Formation in Hypoxia-Induced MDA-MB-231 Breast-Cancer Cell Line
Hypoxia plays a significant role in solid tumors by the increased expression of hypoxia-inducible factor-1α (HIF-1α), which is known to promote cancer invasion and metastasis. Cancer-cell invasion dynamically begins with the degradation of the extracellular matrix (ECM) via invadopodia formation. The chemical substrates that are utilized by hypoxic cells as fuel to drive invadopodia formation are still not fully understood. Therefore, the aim of the study was to maintain MDA-MB-231 cells under hypoxia conditions to allow cells to form a large number of invadopodia as a model, followed by identifying their nutrient utilization. The results of the study revealed an increase in the number of cells forming invadopodia under hypoxia conditions. Moreover, Western blot analysis confirmed that essential proteins for hypoxia and invadopodia, including HIF-1α, vascular endothelial growth factor (VEGF), metallopeptidase-2 (MMP-2), and Rho guanine nucleotide exchange factor 7 (β-PIX), significantly increased under hypoxia. Interestingly, phenotype microarray showed that only 11 chemical substrates from 367 types of substrates were significantly metabolized in hypoxia compared to in normoxia. This is thought to be fuel for hypoxia to drive the invasion process. In conclusion, we found 11 chemical substrates that could have potential energy sources for hypoxia-induced invadopodia formation of these cells. This may in part be a target in the hypoxic tumor and invadopodia formation. Additionally, these findings can be used as potential carrier targets in cancer-drug discovery, such as the usage of dextrin.
Open AccessIdentification of Potential Chemical Substrates as Fuel for Hypoxic Tumors That May Be Linked to Invadopodium Formation in Hypoxia-Induced MDA-MB-231 Breast-Cancer Cell Line
Hypoxia plays a significant role in solid tumors by the increased expression of hypoxia-inducible factor-1α (HIF-1α), which is known to promote cancer invasion and metastasis. Cancer-cell invasion dynamically begins with the degradation of the extracellular matrix (ECM) via invadopodia formation. The chemical substrates that are utilized by hypoxic cells as fuel to drive invadopodia formation are still not fully understood. Therefore, the aim of the study was to maintain MDA-MB-231 cells under hypoxia conditions to allow cells to form a large number of invadopodia as a model, followed by identifying their nutrient utilization. The results of the study revealed an increase in the number of cells forming invadopodia under hypoxia conditions. Moreover, Western blot analysis confirmed that essential proteins for hypoxia and invadopodia, including HIF-1α, vascular endothelial growth factor (VEGF), metallopeptidase-2 (MMP-2), and Rho guanine nucleotide exchange factor 7 (β-PIX), significantly increased under hypoxia. Interestingly, phenotype microarray showed that only 11 chemical substrates from 367 types of substrates were significantly metabolized in hypoxia compared to in normoxia. This is thought to be fuel for hypoxia to drive the invasion process. In conclusion, we found 11 chemical substrates that could have potential energy sources for hypoxia-induced invadopodia formation of these cells. This may in part be a target in the hypoxic tumor and invadopodia formation. Additionally, these findings can be used as potential carrier targets in cancer-drug discovery, such as the usage of dextrin.
- 30 June 2020
- Published by Penerbit Universiti Kebangsaan Malaysia (UKM Press) in Sains Malaysiana
- Vol. 49 (6) , 1359-1370
Zerumbone Induces Cytotoxicity and Inhibits Cell Migration of Human Colon Cancer Cells
- 30 June 2020
- Published by Penerbit Universiti Kebangsaan Malaysia (UKM Press) in Sains Malaysiana
- Vol. 49 (6) , 1359-1370
Zerumbone Induces Cytotoxicity and Inhibits Cell Migration of Human Colon Cancer Cells